Back to products Research use only
However, for musculoskeletal and systemic applications, subcutaneous injection delivers the peptide directly into systemic circulation at predictable concentrations
Studies in animal models of inflammatory bowel disease (IBD) demonstrate BPC-157 can reduce inflammation, promote mucosal healing, and protect against intestinal damage
No, and the reason is irreversible: Gastric enzymes and hydrochloric acid hydrolyze the 29-amino-acid chain before it reaches the bloodstream, leaving free amino acids with no pituitary signaling capacity
enhanced recovery following brain trauma Combined neuroprotective mechanisms remain largely unexplored in controlled studies Wound Healing Research Both peptides show robust wound healing effects through complementary mechanisms[16,17]: BPC-157 : 40-60% improvement in granulation tissue formation
Timeframe Weeks 1-2 Commonly tracked Range-of-motion and functional self-report in case series Notes Reflects symptom-level changes, not structural healing